...
首页> 外文期刊>The International journal of biological markers >Prognostic markers affecting the early recurrence of hepatocellular carcinoma with liver cirrhosis after curative resection
【24h】

Prognostic markers affecting the early recurrence of hepatocellular carcinoma with liver cirrhosis after curative resection

机译:治疗切除后肝硬化肝硬化早期肝细胞癌早期复发的预后标志物

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Early recurrence is associated with poor prognosis after curative resection for hepatocellular carcinoma. Thus, we studied which factors, including this inflammation-based scoring system, affect disease recurrence in single hepatocellular carcinoma patients with liver cirrhosis. Methods: A total of 430 consecutive hepatocellular carcinoma patients were enrolled in our institution between January 2002 and December 2015. Survival rate, univariate, and multivariate analyses were performed to identify the variables associated with recurrence and early recurrence especially. Results: The overall survival rate was significantly lower in the early recurrence group than in the non-early recurrence group (P<0.001). According to the multivariate analysis, protein induced by vitamin K absence or antagonist (PIVKA) greater than 200 (P=0.035), neutrophil-to-lymphocyte ratio greater than 2.0 (P<0.001), elevated Glasgow prognostic score (P=0.003), tumor size greater than 5 cm (P=0.002), and the presence of lymphovascular invasion (P=0.002) were significantly different among the groups and affected the early recurrence of hepatocellular carcinoma. The patients were categorized into five levels of risk for early recurrence according to the number of independent risk factors, and patients with no risk factors were set as the reference group. Conclusion: Neutrophil-to-lymphocyte ratio, Glasgow prognostic score, and serum level of PIVKA offer significant prognostic information associated with early recurrence following single lesion hepatocellular carcinoma patients with liver cirrhosis after curative resection.
机译:背景:早期复发与肝细胞癌治疗切除后的预后不良有关。因此,我们研究了哪些因素,包括这种基于炎症的评分系统,影响肝硬化单一肝细胞癌患者的疾病复发。方法:在2002年1月至2015年12月期间,共有430名连续肝细胞癌患者参加了我们的机构。进行存活率,单变量和多变量分析,以鉴定特别是与复发和早期复发相关的变量。结果:早期复发组总存活率明显低于非早期复发组(P <0.001)。根据多变量分析,由维生素K缺失或拮抗剂(PiVKA)诱导的蛋白质大于200(p = 0.035),中性粒细胞对淋巴细胞比大于2.0(p <0.001),升高的胶质升预期评分(P = 0.003) ,肿瘤大小大于5cm(p = 0.002),并且在组中存在淋巴血管侵袭(p = 0.002),并影响肝细胞癌的早期复发。根据独立危险因素的数量,将患者分为五个早期复发风险,并且没有危险因素的患者被设定为参考组。结论:中性粒细胞对淋巴细胞比率,Glasgow预后评分和血清Pivka的血清水平提供了在治疗切除后单位病变肝细胞癌患者肝硬化后早期复发相关的显着预后信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号